Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management.
about
Cellular and molecular mechanisms of metformin: an overviewPhagocytosis of cholesteryl ester is amplified in diabetic mouse macrophages and is largely mediated by CD36 and SR-A.Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation.Epidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario.Interleukin-1/toll-like receptor-induced nuclear factor kappa B signaling participates in intima hyperplasia after carotid artery balloon injury in goto-kakizaki rats: a potential target therapy pathway.MicroRNA in ischemic stroke etiology and pathology.Pericytopathy: oxidative stress and impaired cellular longevity in the pancreas and skeletal muscle in metabolic syndrome and type 2 diabetes.The association of silent coronary artery disease and metabolic syndrome in Chinese with type 2 diabetes mellitus.Management options for patients with intermittent claudication.Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.Spotlight on endothelial progenitor cell inhibitors: short review.Lipid management reduces cardiovascular complications in individuals with diabetes and prediabetes.Cardiac autonomic neuropathy measured by heart rate variability and markers of subclinical atherosclerosis in early type 2 diabetes.Detecting DNA synthesis of neointimal formation after catheter balloon injury in GK and in Wistar rats: using 5-ethynyl-2'-deoxyuridine.Therapy insight: diabetes and drug-eluting stents.The role of adherence in the relationship between self-efficacy and self-management in diabetic patients undergoing CABG in TaiwanPleiotropic effects of thiazolidinediones.Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction.Factors associated with serum total homocysteine level in type 2 diabetesPathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart.The Role of Immunogenicity in Cardiovascular Disease.Urinary biomarkers involved in type 2 diabetes: a review.Overexpression of STAMP2 suppresses atherosclerosis and stabilizes plaques in diabetic miceSugar and stroke: cerebrovascular disease and blood glucose control.The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.Comparison of cardioprotective efficacy resulting from a combination of atorvastatin and ischaemic post-conditioning in diabetic and non-diabetic rats.The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.Phosphatidylcholine hydroperoxide-induced THP-1 cell adhesion to intracellular adhesion molecule-1.Kidney Injury Molecule Levels in Type 2 Diabetes Mellitus.The effect of metformin on the myocardial tolerance to ischemia-reperfusion injury in the rat model of diabetes mellitus type II.Expression of constitutively active cGMP-dependent protein kinase inhibits glucose-induced vascular smooth muscle cell proliferation.Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.Reductions in diabetic cardiovascular risk by community primary care providers.Iron reduction response and demographic differences between diabetics and non-diabetics with cardiovascular disease entered into a controlled clinical trial.Pharmacokinetic drug evaluation of empagliflozin plus linagliptin for the treatment of type 2 diabetes.Effects of mealtime insulin aspart and bedtime NPH insulin on postprandial inflammation and endothelial cell function in patients with type 2 diabetes.Effects of mealtime insulin aspart and bedtime neutral protamine Hagedorn insulin on postprandial coagulation and fibrinolysis in patients with type 2 diabetes.Post-challenge glucose predicts coronary atherosclerotic progression in non-diabetic, post-menopausal women.Impact of type 2 diabetes mellitus on recurrent myocardial infarction in China.In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome - Data from TSOC ACS-DM Registry.
P2860
Q27013561-5B555385-7393-4677-9AEE-7BDEC87CBFBAQ33286823-7E301A5E-B4CD-4B2F-AAA5-D5FF250ADE97Q33367778-082E7A74-962E-44E2-89E7-EC6475EDE761Q33674543-637C8271-10FC-4811-9826-70957C1B7EF9Q33989455-49E7B001-3E4E-40E1-BA74-32A87EEF4BEFQ34137995-75E40E6D-6B19-4321-A545-F23593EFF178Q35157945-2E267991-57AA-427D-BCDE-85B808A17B7AQ35612618-6B6288ED-E8A5-4CA2-9466-5FA25E1E8270Q35776841-C839DF98-C35A-46F5-98F2-26B7326780DBQ36154232-064B88DB-889B-4D13-951C-B841610ABB7AQ36381012-A312804F-B79E-446F-86DF-A3D7F4F3714BQ36444358-7DE83615-3783-416D-A580-778BCBE6D818Q36464482-9924C336-BD77-453B-A38E-AB9D7680593AQ36510193-008FB154-FBF0-49B8-8E6F-8414F314A896Q36748161-67FA6407-CA8C-49EC-84EE-A79F56A63E70Q36800773-CE5732D7-9BD4-4632-B6FD-A40B7136DA33Q37142044-A852917D-8C5D-4882-ACAB-30896DD3B4FFQ37148331-58773822-E262-442A-9DDA-D14A344DDC6CQ37232270-95AB0E7C-6DC2-44F1-B513-E77CECB9AFB5Q37494520-DED6BFC6-A209-4053-B866-6F0418B30B0AQ37560012-0CEE14E8-1989-4450-B4D0-C1E1E354F643Q37707267-DEB5AF49-71DE-49CA-B588-A68AE0B7A2B6Q37724038-269C2C13-4910-4AA2-A1A4-C2A8FBEC8527Q37759025-899059AA-F3F1-4F73-839E-79AB6BB2FB04Q38200957-8C2129D2-8C95-4054-8FB0-44B706AF14A0Q39529407-082E1545-C65C-472B-BE8F-FE193F403ABDQ39720393-0BEB2A14-CA3D-487B-AA42-B0E30F7B6998Q39900686-ABE9A33D-E25F-464C-9C11-0D95037CBDA7Q40511135-667CD3CF-B494-40A5-9FBC-DB4136C04F79Q42792514-360EDEA3-D7D6-44FC-ADAA-D7A83332B96FQ43283572-865F0B5F-84A1-48E3-80D1-577FE756FAC3Q46080439-0DC3A415-6269-4FD0-BB45-4C2034E05BDBQ46389319-D4D4CA5E-608A-4592-8564-3C47750754E6Q47230788-1A826D21-C727-4ECB-9535-E6E6C3CC41FCQ47293312-E38EA168-AC81-41FB-A93E-9C11D0AE7B1DQ48140197-28783D07-17C6-4AF8-A8F5-4AF1BF4E4A01Q51364256-4A446750-136F-4850-BE1E-0096D618E233Q51466560-DC2A497D-7348-4A14-9FC1-ABF53DD35E88Q53064964-6FE68FEA-B12E-47C5-82C3-565B700B2C64Q55045262-97FE40E3-23B9-416F-8B79-FC89D769B3B2
P2860
Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Increased incidence of coronar ...... us: mechanisms and management.
@ast
Increased incidence of coronar ...... us: mechanisms and management.
@en
type
label
Increased incidence of coronar ...... us: mechanisms and management.
@ast
Increased incidence of coronar ...... us: mechanisms and management.
@en
prefLabel
Increased incidence of coronar ...... us: mechanisms and management.
@ast
Increased incidence of coronar ...... us: mechanisms and management.
@en
P1476
Increased incidence of coronar ...... us: mechanisms and management.
@en
P2093
R Todd Hurst
Richard W Lee
P304
P356
10.7326/0003-4819-139-10-200311180-00010
P407
P577
2003-11-01T00:00:00Z